Evidence map›Paper›PMID 19104365›Full record

ArticleObstetrics and gynecology2009

Prediction of treatment outcomes after global endometrial ablation.

Sherif A El-Nashar, Matthew R Hopkins, Douglas J Creedon, Jennifer L St Sauver, Amy L Weaver, Michaela E McGree, William A Cliby, Abimbola O Famuyide

Erratum issued 2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Obstetrics and gynecology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02584088 completednot on this mapstarted 2016, after this paper: background citation

Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation

TypeobservationalSponsorTriHealth Inc.Ran2016 to 2021Enrolled80ConditionsMenorrhagiaArmsUltrasound
NCT05483348 completednot on this mapstarted 2022, after this paper: background citation

Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection; Retrospective Study at a Tertiary University Hospital

TypeobservationalSponsorNaser Al-HusbanRan2022 to 2022Enrolled95ConditionsUterine Bleeding, Treatment Failures, Prognostic FactorsArmsEndometrial Ablation, Repeated gynecological procedure
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022
    Article
  6. Article
  7. Late-onset endometrial ablation failure.Case reports in women's health · 2017
    Review
  8. Article
  9. Article
  10. Ambulatory management of heavy menstrual bleeding.Women's health (London, England) · 2016
    Review
  11. Endometrial ablation for heavy menstrual bleeding.Women's health (London, England) · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Thermal balloon endometrial ablation in dysfunctional uterine bleeding.Journal of gynecological endoscopy and surgery · 2009
    Article
  18. Article
  19. Characteristics of patients undergoing hysterectomy for failed endometrial ablation.JSLS : Journal of the Society of Laparoendoscopic Surgeons
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sherif A El-NasharFrom the Divisions of Gynecology, Epidemiology, Biostatistics, and Gynecologic Surgery, Mayo Clinic, Rochester, Minnesota.
Matthew R Hopkins
Douglas J Creedon
Jennifer L St Sauver
Amy L Weaver
Michaela E McGree
William A Cliby
Abimbola O Famuyide
Cancer Research And Biostatistics · USMayo Clinic · US

Funding

ROCHESTER EPIDEMIOLOGY PROJECTR01AR030582 · NIAMS · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A · 1986 to 2009
$5.1M
NIAMS NIH HHS AR30582-43NIAMS NIH HHS R01 AR030582
6 · The paper itself

Abstract

objectiveTo report rates of amenorrhea and treatment failure after global endometrial ablation and to estimate the association between patient factors and these outcomes by developing and validating prediction models.

methodsFrom January 1998 through December 2005, 816 women underwent global endometrial ablation with either a thermal balloon ablation or radio frequency ablation device; 455 were included in a population-derived cohort (for model development), and 361 were included in a referral-derived cohort (for model validation). Amenorrhea was defined as cessation of bleeding from immediately after ablation through at least 12 months after the procedure. Treatment failure was defined as hysterectomy or reablation for patients with bleeding or pain. Logistic and Cox proportional hazard regression models were used in model development and validation of potential predictors of outcomes.

resultsThe amenorrhea rate was 23% (95% confidence interval [CI] 19-28%) and the 5-year cumulative failure rate was 16% (95% CI 10-20%). Predictors of amenorrhea were age 45 years or older (adjusted odds ratio [aOR] 2.6, 95% CI 1.6-4.3); uterine length less than 9 cm (aOR 1.8, 95% CI 1.1-3.1); endometrial thickness less than 4 mm (aOR 2.7, 95% CI 1.2-6.3); and use of radio-frequency ablation instead of thermal balloon ablation (aOR 2.8, 95% CI 1.7-4.9). Predictors of treatment failure included age younger than 45 years (adjusted hazard ratio [aHR] 2.6, 95% CI 1.3-5.1); parity of 5 or greater (aHR 6.0, 95% CI 2.5-14.8); prior tubal ligation (aHR 2.2, 95% CI 1.2-4.0); and history of dysmenorrhea (aHR 3.7, 95% CI 1.6-8.5). After global endometrial ablation, 23 women (5.1%, 95% CI 3.2-7.5%) had pelvic pain, three (0.7%, 95% CI 0.1-1.9%) were pregnant, and none (95% CI 0-0.8%) had endometrial cancer.

conclusionPopulation-derived rates and predictors of treatment outcomes after global endometrial ablation may help physicians offer optimal preprocedural patient counseling. LEVEL OF EVIDENCE: II.

Indexed as

Endometrial Ablation TechniquesAdultAmenorrheaFemaleHumansHysterectomyMenorrhagiaMiddle AgedRetreatmentTreatment FailureTreatment Outcome

Identifiers

PMID19104365
PMCPMC2977517
OpenAlexW2038507292

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.